HeadlinesBriefing.com

Eir Partners backs life science tech firm QuartzBio

PE Hub • May 13, 2026 at 8:53 AM ET

×

QuartzBio provides sample and biomarker intelligence for clinical‑stage biopharma.The post Eir Partners backs life science tech firm QuartzBio appeared first on PE Hub.

Read original article

Source: PE Hub · Summarized by HeadlinesBriefing

Related articles

Alibaba Leaders’ Buying Does Little to Ease Share Sale Fallout
Alphabet Loses $692 Billion in Market Value as AI Questions Rise
Asian Stocks Set to Extend AI Chip-Fueled Selloff: Markets Wrap
Asia Tech Shares Swing Wildly as A.I. Jitters Persist
Advantest Shares Decline After Outlook Misses on Tight Capacity

More from PE Hub

Spectrum Equity makes first institutional investment in hospital data firm Symmetric
BDT & MSD agrees to acquire Sunrise Senior Living from PSP Investments
Altaris completes carve-out of Clarivate’s life sciences and healthcare business
North Branch Capital backs industrial maintenance provider Callaway Industrial Services
Sojourner aims to broaden personal care capabilities with LPNA merger; Main Capital, Gemspring, One Equity bet on cybersecurity

Latest in Private Markets

Ardian: ‘We’ve been less shy on factoring growth into our business plans’ · Infrastructure Investor
7 Cambridge alumni building in stealth · Sifted
Bending Spoons CEO on why M&A fails · Sifted
Robot data startup Mecka AI nabs $60M from Sequoia · TechCrunch Venture
Who’s key in a CV? · Infrastructure Investor

Related briefings

Markets 24-Hour Briefing Markets 8-Hour Briefing

Home
Private Markets
Eir Partners backs life science tech firm QuartzBio

Sections

Home Public Markets Private Markets Tech & Games Mobile Developer F1 Sports